Loading clinical trials...
Loading clinical trials...
SRT Versus WBRT Combined With Pyrrotinib and Capecitabine in the Treatment of HER2-positive Advanced Breast Cancer Patients With Brain Metastases: A Randomized Controlled, Prospective Clinical Study
Conditions
Interventions
radiation combined with pyrotinib and capecitabine
Locations
1
China
Jiangxi Cancer Hospital of Nanchang University
Nanchang, Jiangxi, China
Start Date
March 1, 2022
Primary Completion Date
September 30, 2025
Completion Date
September 30, 2025
Last Updated
February 9, 2024
NCT06625775
NCT05800275
NCT06551116
NCT03417544
NCT05230810
NCT06305702
Lead Sponsor
Jiangxi Provincial Cancer Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions